Tokyo, April 16 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061272) titled 'Time Course of Exhaled Hydrogen Concentration Following Oral Administration of a Hydrogen-Rich Jelly' on April 15.
Study Type:
Interventional
Study Design:
Basic Design - Single arm
Randomization - Non-randomized
Blinding - Open -no one is blinded
Control - Self control
Primary Sponsor:
Institute - Hiroshima University
Condition:
Condition - Healthy
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To evaluate the time course of exhaled hydrogen concentration following oral administration of a hydrogen-rich jelly
Basic objectives2 - Others
Intervention:
Interventions/Control_1 - At the first test session, participants consume the same standardized commercially available meal, and at the second test session, they consume hydrogen-rich jelly (10 g containing 0.3 mg of hydrogen). Exhaled hydrogen concentration is measured over time after each intake. A 1-week washout period is provided between the two test sessions.
Eligibility:
Age-lower limit - 20
years-old
=
Gender - Male and Female
Key inclusion criteria - Healthy
Key exclusion criteria - 1) Individuals currently taking medicines and/or dietary supplements
2) Individuals with food allergies
3) Individuals currently participating in another clinical study, or who have participated in another clinical study within the past 3 months
4) Individuals who are pregnant, may be pregnant, or are breastfeeding
5) Individuals judged by the principal investigator or sub-investigator to be ineligible for participation in this study
Target Size - 20
Recruitment Status:
Recruitment status - Open public recruiting
Date of protocol fixation - 2026 Year 04 Month 14 Day
Date of IRB - 2026 Year 04 Month 14 Day
Anticipated trial start date - 2026 Year 04 Month 15 Day
Last follow-up date - 2027 Year 05 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069605
Disclaimer: Curated by HT Syndication.